4.7 Article

The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity

Journal

NATURE IMMUNOLOGY
Volume 20, Issue 3, Pages 337-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41590-018-0311-z

Keywords

-

Categories

Funding

  1. Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Center for Cancer Research [ZIABC011480]
  2. US National Institutes of Health [GM100776, CA85842]
  3. Wellcome Trust/Royal Society [105663/Z/14/Z]
  4. UK Biotechnology and Biological Sciences Research Council [BB/N007794/1]
  5. Cancer Research UK [C52623/A22597]
  6. Wellcome Trust [105663/Z/14/Z] Funding Source: Wellcome Trust
  7. BBSRC [BBS/E/B/000C0428, BBS/E/B/000C0427, BBS/E/B/000C0409, BB/N007794/1, 1642652, BBS/E/B/000C0407] Funding Source: UKRI
  8. MRC [MR/S024468/1, 1947452, MC_UP_1502/3] Funding Source: UKRI
  9. NATIONAL CANCER INSTITUTE [ZIABC011633] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Stem cells are maintained by transcriptional programs that promote self-renewal and repress differentiation. Here, we found that the transcription factor c-Myb was essential for generating and maintaining stem cells in the CD8(+) T cell memory compartment. Following viral infection, CD8(+) T cells lacking Myb underwent terminal differentiation and generated fewer stem cell-like central memory cells than did Myb-sufficient T cells. c-Myb acted both as a transcriptional activator of Tcf7 (which encodes the transcription factor Tcf1) to enhance memory development and as a repressor of Zeb2 (which encodes the transcription factor Zeb2) to hinder effector differentiation. Domain-mutagenesis experiments revealed that the transactivation domain of c-Myb was necessary for restraining differentiation, whereas its negative regulatory domain was critical for cell survival. Myb overexpression enhanced CD8(+) T cell memory formation, polyfunctionality and recall responses that promoted curative antitumor immunity after adoptive transfer. These findings identify c-Myb as a pivotal regulator of CD8(+) T cell stemness and highlight its therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available